Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. (Q48501830)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. |
scientific article published in February 2006 |
Statements
1 reference
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. (English)
1 reference
Joseph Biederman
1 reference
Timothy E Wilens
1 reference
Thomas J Spencer
1 reference
Richard H Weisler
1 reference
Stephanie C Read
1 reference
Raymond Pratt
1 reference
1 February 2006
1 reference
1 reference
28
1 reference
2
1 reference
266-279
1 reference
Identifiers
1 reference
1 reference